Patel Aayushi N, Amrutiya Rahulkumar J, Manvar Buddhadev N
Clinical Research, Tampa General Hospital, Tampa, USA.
Cardiology, St. Jude Medical Center, New York City, USA.
Cureus. 2022 Aug 27;14(8):e28481. doi: 10.7759/cureus.28481. eCollection 2022 Aug.
Clot-in-transit (CIT) is defined as a mobile echogenic material in the right atrium or ventricle as observed on ultrasound. A right heart free-floating thrombus is unusual when there is no structural disease of the heart or atrial fibrillation. Cardiopulmonary collapse and quick death can come from CIT, which occurs when a blood clot moves from the heart to the lungs. There are some clinical case reports of a large volume thrombus that was freely floating in the right heart in an asymptomatic patient, and the best therapeutic options are uncertain. Although several trials have been conducted on the treatment of CIT, clinical judgment is still used to determine the best treatment for right heart thrombus (RHT), especially when associated with pulmonary embolism (PE). In this review article, we discuss various diagnostic modalities and treatment options for this rare malady. We studied in detail their clinical impact on patients according to past research studies.
移动性血栓（CIT）定义为超声检查时在右心房或右心室中观察到的可移动的强回声物质。在没有心脏结构疾病或房颤的情况下，右心游离血栓并不常见。CIT可导致心肺功能衰竭和猝死，它发生在血凝块从心脏移动到肺部时。有一些临床病例报告称，在无症状患者中，有大量血栓在右心自由漂浮，而最佳治疗方案尚不确定。尽管已经进行了多项关于CIT治疗的试验，但对于右心血栓（RHT），尤其是与肺栓塞（PE）相关的右心血栓，仍需临床判断来确定最佳治疗方法。在这篇综述文章中，我们讨论了这种罕见疾病的各种诊断方法和治疗选择。我们根据以往的研究详细研究了它们对患者的临床影响。
